Leonard Braden Michael's Form 4 filing
OnKure Therapeutics, Inc. (OKUR) · filed Sep 16, 2024
- Accession no.
- 0001373604-24-000090
- Filed
- Sep 16, 2024
- Trade date
- Sep 12-16, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $483.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leonard Braden MichaelCIK 0001373603 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2024 | Common Stock | PPurchaseAcquired | +36,176 | $1.40 | +$50,646.4 | 2,980,196 | Indirect | |
| Sep 13, 2024 | Common Stock | PPurchaseAcquired | +150,000 | $1.31 | +$196,500 | 3,130,196 | Indirect | |
| Sep 16, 2024 | Common Stock | PPurchaseAcquired | +172,747 | $1.37 | +$236,663.39 | 3,302,943 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.